Publications by authors named "Christopher Luscombe"

Claim this Profile
M
MELLODDY: Cross-pharma Federated Learning at Unprecedented Scale Unlocks Benefits in QSAR without Compromising Proprietary Information.
Wouter Heyndrickx, Lewis Mervin, Tobias Morawietz, Noé Sturm, Lukas Friedrich, Christopher Luscombe

J Chem Inf Model· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Arterio-Ureteral Fistula: A Rare Elusive Cause of Significant Hematuria.
Muhammad Waqar, Suresh-Jay Mathias, Vinodh Murali, Helen Thursby, Christopher Luscombe

Cureus· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Day-case catheterless and drainless minimal-access pyeloplasty in adults: A single-center experience of 13 years.
Vinodh Murali, Jack Donati-Bourne, Megan Thomas, Christopher Luscombe, Anurag Golash

Int J Urol· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Using Physicochemical Measurements to Influence Better Compound Design.
Shenaz B Bunally, Christopher N Luscombe, Robert J Young

SLAS Discov· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HumanMethylation450K Array-Identified Biomarkers Predict Tumour Recurrence/Progression at Initial Diagnosis of High-risk Non-muscle Invasive Bladder Cancer.
Mark O Kitchen, Richard T Bryan, Richard D Emes, Christopher J Luscombe, K K Cheng

Biomark Cancer· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to Evolution of a Novel, Orally Bioavailable Series of PI3Kδ Inhibitors from an Inhaled Lead for the Treatment of Respiratory Disease.
Augustin Amour, Nick Barton, Anthony W J Cooper, Graham Inglis, Craig Jamieson, Christopher N Luscombe

J Med Chem· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to Evolution of a Novel, Orally Bioavailable Series of PI3Kδ Inhibitors from an Inhaled Lead for the Treatment of Respiratory Disease.
Augustin Amour, Nick Barton, Anthony W J Cooper, Graham Inglis, Craig Jamieson, Christopher N Luscombe

J Med Chem· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evolution of a Novel, Orally Bioavailable Series of PI3Kδ Inhibitors from an Inhaled Lead for the Treatment of Respiratory Disease.
Augustin Amour, Nick Barton, Anthony W J Cooper, Graham Inglis, Craig Jamieson, Christopher N Luscombe

J Med Chem· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Methylation of HOXA9 and ISL1 Predicts Patient Outcome in High-Grade Non-Invasive Bladder Cancer.
Mark O Kitchen, Richard T Bryan, Kim E Haworth, Richard D Emes, Christopher Luscombe

PLoS One· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrating in Silico and in Vitro Approaches To Predict Drug Accessibility to the Central Nervous System.
Yan-Yan Zhang, Houfu Liu, Scott G Summerfield, Christopher N Luscombe, Jasminder Sahi

Mol Pharm· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitative genome-wide methylation analysis of high-grade non-muscle invasive bladder cancer.
Mark O Kitchen, Richard T Bryan, Richard D Emes, John R Glossop, Christopher Luscombe

Epigenetics· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A unique presentation, and management, of acute urinary retention in a young boy with underlying vesicoureteral reflux.
Chirag Patel, Vaibhav Modgil, Christopher Luscombe, Samson Liu

J Surg Case Rep· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
QSAR workbench: automating QSAR modeling to drive compound design.
Richard Cox, Darren V S Green, Christopher N Luscombe, Noj Malcolm, Stephen D Pickett

J Comput Aided Mol Des· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Getting physical in drug discovery II: the impact of chromatographic hydrophobicity measurements and aromaticity.
Robert J Young, Darren V S Green, Christopher N Luscombe, Alan P Hill

Drug Discov Today· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An objective scoring system for laparoscopic nephrectomy.
Sashi S Kommu, Amr M Emara, Philip James, Thomas Finnigan, David Cartlidge, Christopher J Luscombe

J Endourol· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Routine day-case laparoscopic pyeloplasty: a paradigm shift?
Cristian P Ilie, Christopher J Luscombe, Ian Smith, Jane Boddy, Dan Mischianu

J Endourol· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Day case laparoscopic nephrectomy.
Cristian P Ilie, Christopher J Luscombe, Ian Smith, Jane Boddy, Dan Mischianu

J Endourol· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Initial treatment costs of organ-confined prostate cancer: a general perspective.
Sashi S Kommu, Christopher G Eden, Christopher J Luscombe, Anurag Golash, Rajendra A Persad

BJU Int· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lead optimization using matched molecular pairs: inclusion of contextual information for enhanced prediction of HERG inhibition, solubility, and lipophilicity.
George Papadatos, Muhammad Alkarouri, Valerie J Gillet, Peter Willett, Visakan Kadirkamanathan, Christopher N Luscombe

J Chem Inf Model· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of the calculated physicochemical properties of respiratory drugs: can we design for inhaled drugs yet?
Timothy J Ritchie, Christopher N Luscombe, Simon J F Macdonald

J Chem Inf Model· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Laparoendoscopic single-site surgery (less) and notes; standardised platforms in nomenclature.
Sashi S Kommu, Aniruddha Chakravarti, Christopher J Luscombe, Anrag Golash, Mihir M Desai

BJU Int· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nephron-sparing surgery: a call for greater application of established techniques.
James G Young, Christopher J Luscombe, Ciaran Lynch, D Michael A Wallace

BJU Int· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Associations between timing of exposure to ultraviolet radiation, T-stage and survival in prostate cancer.
Nick Rukin, Miliça Blagojevic, Christopher J Luscombe, Samson Liu, Mark F Saxby

Cancer Detect Prev· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Re: A systematic review of vitamin D receptor gene polymorphisms and prostate cancer risk. S. I. Berndt, J. L. Dodson, W. Y. Huang and K. K. Nicodemus, J Urol 2006; 175: 1613-1623.
Nicholas John Rukin, Christopher J Luscombe, Richard C Strange

J Urol· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determination of selectivity differences for basic compounds in gradient reverse phase high performance liquid chromatography under high pH conditions by partial least squares modelling.
Emilia Fornal, Phil Borman, Christopher Luscombe

Anal Chim Acta· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis